MPS Pharmaa has been growing earnings at an average annual rate of 32.2%, while the Pharmaceuticals industry saw earnings growing at 14.7% annually. Revenues have been declining at an average rate of 31.2% per year.
Key information
32.16%
Earnings growth rate
32.02%
EPS growth rate
Pharmaceuticals Industry Growth
17.49%
Revenue growth rate
-31.20%
Return on equity
-1,489.05%
Net Margin
-2,865.17%
Next Earnings Update
13 Aug 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How MPS Pharmaa makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BSE:531686 Revenue, expenses and earnings (INR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
0
-10
5
0
31 Dec 25
0
-9
5
0
30 Sep 25
0
-9
5
0
30 Jun 25
0
-9
5
0
31 Mar 25
0
-9
5
0
31 Dec 24
1
-9
5
0
30 Sep 24
0
-9
5
0
30 Jun 24
1
-9
5
0
31 Mar 24
1
-8
5
0
31 Dec 23
1
-9
5
0
30 Sep 23
1
-9
5
0
30 Jun 23
1
-10
5
0
31 Mar 23
0
-11
5
0
31 Dec 22
0
-3
5
0
30 Sep 22
0
-3
5
0
30 Jun 22
0
-1
4
0
31 Mar 22
0
-1
4
0
31 Dec 21
3
-7
-30
0
30 Sep 21
3
-42
4
0
30 Jun 21
2
-44
39
0
31 Mar 21
0
-44
4
0
31 Dec 20
0
-46
39
0
30 Sep 20
0
-11
4
0
30 Jun 20
0
-12
4
0
31 Mar 20
0
-12
5
0
31 Dec 19
0
-11
5
0
30 Sep 19
0
-12
5
0
30 Jun 19
9
-12
5
0
31 Mar 19
8
-12
5
0
31 Dec 18
9
-11
6
0
30 Sep 18
21
-11
6
0
30 Jun 18
28
-10
6
0
31 Mar 18
41
-9
7
0
31 Dec 17
46
-34
9
0
30 Sep 17
44
-34
9
0
30 Jun 17
37
-35
10
0
31 Mar 17
29
-74
10
0
31 Dec 16
32
-44
9
0
30 Sep 16
3
-46
9
0
30 Jun 16
-3
-47
8
0
31 Mar 16
14
-12
10
0
31 Dec 15
19
-21
14
0
30 Sep 15
67
-17
14
0
Quality Earnings: 531686 is currently unprofitable.
Growing Profit Margin: 531686 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 531686 is unprofitable, but has reduced losses over the past 5 years at a rate of 32.2% per year.
Accelerating Growth: Unable to compare 531686's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 531686 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.1%).
Return on Equity
High ROE: 531686 has a negative Return on Equity (-1489.05%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/10 18:57
End of Day Share Price
2026/08/10 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MPS Pharmaa Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.